AF
ALNY icon

Allworth Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Allworth Financial’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Sell
1,099
-184
-14% -$55.5K ﹤0.01% 1207
2026
Q1 		$425K Sell
1,283
-70
-5% -$23.8K ﹤0.01% 1022
2025
Q4 		$538K Buy
1,353
+63
+5% +$27.9K ﹤0.01% 905
2025
Q3 		$588K Buy
1,290
+599
+87% +$244K ﹤0.01% 832
2025
Q2 		$225K Buy
691
+73
+12% +$20.2K ﹤0.01% 1130
2025
Q1 		$150K Buy
618
+21
+4% +$5.4K ﹤0.01% 1055
2024
Q4 		$159K Buy
597
+38
+7% +$9.99K ﹤0.01% 1034
2024
Q3 		$154K Sell
559
-6
-1% -$1.56K ﹤0.01% 907
2024
Q2 		$134K Sell
565
-26
-4% -$4.11K ﹤0.01% 957
2024
Q1 		$88.3K Buy
591
+346
+141% +$57.7K ﹤0.01% 1065
2023
Q4 		$46.9K Sell
245
-16
-6% -$2.73K ﹤0.01% 1227
2023
Q3 		$46.2K Buy
261
+42
+19% +$8.01K ﹤0.01% 1149
2023
Q2 		$41.6K Buy
219
+36
+20% +$7.14K ﹤0.01% 1182
2023
Q1 		$36.7K Buy
183
+3
+2% +$631 ﹤0.01% 1184
2022
Q4 		$42.8K Sell
180
-6
-3% -$1.28K ﹤0.01% 1068
2022
Q3 		$37K Buy
186
+163
+709% +$31.1K ﹤0.01% 1062
2022
Q2 		$3K Buy
23
+8
+53% +$1.14K ﹤0.01% 1868
2022
Q1 		$2K Sell
15
-46
-75% -$7.01K ﹤0.01% 1769
2021
Q4 		$10K Buy
+61
New +$11.3K ﹤0.01% 1368

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's ALNY Position: Q2 2026 in Review

Allworth Financial reduced its Alnylam Pharmaceuticals (ALNY) stake by 14% in Q2 2026, selling an estimated $55.5K and leaving 1,099 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Allworth Financial first reported a position in ALNY in Q4 2021 and has held it in 19 quarters since. The position peaked at $588K in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Allworth Financial held 1,099 shares of Alnylam Pharmaceuticals worth $331K as of Q2 2026.
  • Allworth Financial sold 184 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $55.5K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1207 holding.
  • Allworth Financial first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Allworth Financial's Alnylam Pharmaceuticals position peaked at $588K in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.